Provectus Pharmaceuticals, Inc. Stock price OTC Bulletin Board
Equities
PVCT
US74373F1003
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Financials (USD)
Sales 2021 | - | Sales 2022 | 0.99 | Capitalization | 45.43M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -3M | EV / Sales 2021 | - |
Net Debt 2021 | 1.06M | Net Debt 2022 | 2.16M | EV / Sales 2022 | 48,121,944 x |
P/E ratio 2021 |
-4.05
x | P/E ratio 2022 |
-12.8
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 17-04-02 | |
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
John W. Lacey
BRD | Director/Board Member | 76 | 18-04-26 |
Chief Executive Officer | 55 | 17-04-02 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-36.53% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Provectus Biopharmaceuticals, Inc.
- Stock Provectus Pharmaceuticals, Inc. - OTC Bulletin Board